INOVIO PHARMACEUTICALS, INC.
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
INO | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 660 W. GERMANTOWN PIKE, 19462 PLYMOUTH MEETING
- Website:
- https://www.inovio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
INOVIO PHARMACEUTICALS, INC. is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of DNA medicines. The company's proprietary platform designs DNA plasmids—small, circular DNA molecules that instruct the body's cells to produce specific proteins to target and fight disease. These DNA medicines are delivered directly into cells using INOVIO's proprietary investigational CELLECTRA® smart devices. This delivery method is designed for optimal effect without the use of chemical adjuvants, lipid nanoparticles, or viral vectors. INOVIO's development pipeline is focused on treatments and preventives for HPV-related diseases, cancer, and infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all INOVIO PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for INOVIO PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for INOVIO PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
